Phase IIa Multicentre Study Investigating of VR040 in Parkinson's Disease

Summary

'Off periods' where people with Parkinson's disease are slow, stiff and unable to function are disabling, and a treatment which can converts people to a "on", good, able to function state would be extremely useful. We assessed safety, tolerability and efficacy of inhaled dry powder apomorphine (VR040) in a clinic-based study in this setting.

Timeline

Start

2007-03

Primary completion

2007-07

Completion

2009-07

Drugs

Indications